Induction of antibodies by Staphylococcus aureus nasal colonization in young children

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1312-1317

  Verkaik, N J ^a   Lebon, A ^a,b   de Vogel, C P ^a   Hooijkaas, H ^a   Verbrugh, H A ^a   Jaddoe, V W V ^a,b   Hofman, A ^a   Moll, H A ^a,b   van Belkum, A ^a   van Wamel, W J B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Antibodies; Children; Colonization; Luminex; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; BIOLOGICAL MARKER; CATALASE; CHEMOTAXIS INHIBITORY PROTEIN; CLUMPING FACTOR A; EXTRACELLULAR FIBRINOGEN BINDING PROTEIN; HYDROPEROXIDE DERIVATIVE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IRON RESPONSIVE SURFACE DETERMINANT A; TEICHOIC ACID; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CELL SURFACE RECEPTOR; CHEMOTAXIS INHIBITORY PROTEIN, STAPHYLOCOCCUS AUREUS; COMPLEMENT INHIBITOR; EHP PROTEIN, STAPHYLOCOCCUS AUREUS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISDA PROTEIN, STAPHYLOCOCCUS AUREUS; ISDH PROTEIN, STAPHYLOCOCCUS AUREUS;

ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DOWN REGULATION; EARLY CHILDHOOD INTERVENTION; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; IN VIVO STUDY; INFANT; INFECTION PREVENTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NOSE INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UPREGULATION; AGE; BLOOD; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; NOSE MUCOSA; PASSIVE IMMUNIZATION; PROCEDURES;

AGE FACTORS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARRIER STATE; CHILD, PRESCHOOL; COMPLEMENT INACTIVATOR PROTEINS; FLOW CYTOMETRY; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; NASAL MUCOSA; RECEPTORS, CELL SURFACE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77955156286     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03073.x     Document Type: Article

References (29)

1. Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963, 27:56-71.
2. Wertheim HF, Melles DC, Vos MC. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5:751-762.
3. van Belkum A, Verkaik NJ, de Vogel CP. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 2009, 199:1820-1826.
4. Regev-Yochay G, Dagan R, Raz M. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 2004, 292:716-720.
5. Lebon A, Labout JA, Verbrugh HA. Dynamics and determinants of Staphylococcus aureus carriage in infancy: the Generation R study. J Clin Microbiol 2008, 46:3517-3521.
6. Peacock SJ, Justice A, Griffiths D. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003, 41:5718-5725.
7. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10:505-520.
8. Weidenmaier C, Kokai-Kun JF, Kristian SA. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004, 10:243-245.
9. Cosgrove K, Coutts G, Jonsson IM. Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol 2007, 189:1025-1035.
10. Clarke SR, Brummell KJ, Horsburgh MJ. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 2006, 193:1098-1108.
11. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJ. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol 2002, 4:759-770.
12. Roche FM, Meehan M, Foster TJ. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 2003, 149:2759-2767.
13. Wertheim HF, Walsh E, Choudhurry R. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med 2008, 5:e17(0104-0112).
14. Jaddoe VW, Bakker R, van Duijn CM. The Generation R study biobank: a resource for epidemiological studies in children and their parents. Eur J Epidemiol 2007, 22:917-923.
15. Jaddoe VW, van Duijn CM, van der Heijden AJ. The Generation R study: design and cohort update until the age of 4 years. Eur J Epidemiol 2008, 23:801-811.
16. Verkaik NJ, de Vogel CP, Boelens HA. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis 2009, 199:625-632.
17. Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998, 6:484-488.
18. Balaban N, Rasooly A. Staphylococcal enterotoxins. Int J Food Microbiol 2000, 61:1-10.
19. Shannon O, Uekotter A, Flock JI. The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus. Scand J Immunol 2006, 63:184-190.
20. Jongerius I, Kohl J, Pandey MK. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 2007, 204:2461-2471.
21. de Haas CJ, Veldkamp KE, Peschel A. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004, 199:687-695.
22. Martins TB, Augustine NH, Hill HR. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci. J Immunol Methods 2006, 316:97-106.
23. Verkaik N, Brouwer E, Hooijkaas H, van Belkum A, van Wamel W. Comparison of carboxylated and penta-his microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins. J Immunol Methods 2008, 335:121-125.
24. Stoop JW, Zegers BJ, Sander PC, Ballieux RE. Serum immunoglobulin levels in healthy children and adults. Clin Exp Immunol 1969, 4:101-112.
25. Janeway CA. The immune system in health and disease. Immunobiology 2005, 6:474-476. Janeway CATravers PWalport MShlomchik MJ. In, eds, 6th edn, New York, Garland Science Publishing
26. Rojas R, Apodaca G. Immunoglobulin transport across polarized epithelial cells. Nat Rev 2002, 3:944-955.
27. Yoshida M, Masuda A, Kuo TT. IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin Immunopathol 2006, 28:397-403.
28. Fattom A, Fuller S, Propst M. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (staphvax) in hemodialysis patients. Vaccine 2004, 23:656-663.
29. Verbrugh HA, Peters R, Rozenberg-Arska M, Peterson PK, Verhoef J. Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. J Infect Dis 1981, 144:1-9.